Join the Women in Retina networking breakfast being held Saturday, October 3, 2026, from 07:30 – 09:00 CEST (no pre-registration required), Location: World Retina Plaza.
The Euretina Session track at the 2026 Congress began on Thursday morning with a programme titled “Eye Openers”. In this video-based interactive session, six experienced retina specialists presented lessons learned from challenging vitreoretinal surgery cases. At junctures when complications occurred throughout the cases, input on next steps was sought from a faculty panel and audience members equipped with electronic response keypads.
Eye Openers: Master Surgeons Share Hard-Won Lessons and Surgical Rescue Strategies Read More »
Euretina lecturer delineates research challenges, progress, and strategies for addressing knowledge gaps and treatment needs for dry age-related macular degeneration.
Euretina Lecture Preview: The Dark Side of the Moon: New Horizons in Dry AMD Read More »
At the beginning of her keynote address on Artificial Intelligence (AI) in Medicines Development: Perspective From an EU Medicines Regulator, Jane Moseley, Senior Scientific Officer at the European Medicines Agency (EMA) said she would be addressing three key questions: Where do we want to get to with AI in medicines development?; Where are we now?; and How are we going to get there?
Elevating Science: Explore the Revamped Free Paper Forums and Poster Hub Read More »
The 4th annual EURETINA Innovation Spotlight (EIS) held on Wednesday afternoon proved again that the programme is a rich educational opportunity for all attendees and a valuable forum for networking and collaboration. Therefore, it is easy to understand why the EIS has become a not-to-be-missed event for physicians, researchers, and industry representatives attending the EURETINA Congress.
EURETINA Innovation Spotlight (EIS) Kicks Off Vienna Congress in Style Read More »
The Investor Panel at EIS 2026 compromised an international group of four participants who answered questions posed by moderators Kourous Rezaei, MD and Martin Zinkernagel, MD, PhD.
At the beginning of her keynote address on Artificial Intelligence (AI) in Medicines Development: Perspective From an EU Medicines Regulator, Jane Moseley, Senior Scientific Officer at the European Medicines Agency (EMA) said she would be addressing three key questions: Where do we want to get to with AI in medicines development?; Where are we now?; and How are we going to get there?
AI in Medicines Development: EMA Shares Progress, Risks, and Regulatory Roadmap Read More »
Survey participants will be entered into a raffle to receive a free registration for the EURETINA 2027 Congress and will receive a summary report before it is published.
Ninth Annual EURETINA Clinical Trends Survey Underway: Your Participation is Essential! Read More »
Kreissig Award lecturer reviews the evidence base and scientific rationale for use of vitreous cavity tamponades in the repair of rhegmatogenous retinal detachment and looks ahead to the possibility of a tamponade-free future.
